Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Ochola, Lucy B ^a   Siddondo, Bethsheba R ^a   Ocholla, Harold ^a   Nkya, Siana ^c   Kimani, Eva N ^a   Williams, Thomas N ^a,f   Makale, Johnstone O ^a   Liljander, Anne ^d   Urban, Britta C ^a,b   Bull, Pete C ^a,e   Szestak, Tadge ^b   Marsh, Kevin ^a,e   Craig, Alister G ^b  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1;

ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN MALARIA; CELL ADHESION; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; GENOTYPE; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; MALARIA FALCIPARUM; NONHUMAN; PARASITE ISOLATION; PHENOTYPE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PROTEIN BINDING; PROTEIN FUNCTION; CYTOLOGY; GENETICS; INFANT; ISOLATION AND PURIFICATION; METABOLISM; PARASITOLOGY; PATHOLOGY;

PLASMODIUM FALCIPARUM;

ANTIGENS, CD36; CELL ADHESION; CHILD; CHILD, PRESCHOOL; GENOTYPE; HOST-PARASITE INTERACTIONS; HUMANS; INFANT; INTERCELLULAR ADHESION MOLECULE-1; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 79952284686     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014741     Document Type: Article

References (95)

1. Turner GD, Morrison H, Jones M, Davis TM, Looareesuwan S, et al. (1994) An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 145: 1057-1069.
2. Ho M, White NJ, (1999) Molecular mechanisms of cytoadherence in malaria. Am J Physiol 276: C1231-1242.
3. Miller LH, Baruch DI, Marsh K, Doumbo OK, (2002) The pathogenic basis of malaria. Nature 415: 673-679.
4. Rowe JA, Claessens A, Corrigan RA, Arman M, (2009) Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med 11: e16.
5. Silamut K, Phu NH, Whitty C, Turner GD, Louwrier K, et al. (1999) A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol 155: 395-410.
6. Newbold C, Warn P, Black G, Berendt A, Craig A, et al. (1997) Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg 57: 389-398.
7. Rowe A, Obeiro J, Newbold CI, Marsh K, (1995) Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 63: 2323-2326.
8. Rowe JA, Rogerson SJ, Raza A, Moulds JM, Kazatchkine MD, et al. (2000) Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. J Immunol 165: 6341-6346.
9. Horata N, Kalambaheti T, Craig A, Khusmith S, (2009) Sequence variation of PfEMP1-DBLalpha in association with rosette formation in Plasmodium falciparum isolates causing severe and uncomplicated malaria. Malar J 8: 184.
10. Fried M, Duffy PE, (1996) Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272: 1502-1504.
11. Maubert B, Fievet N, Tami G, Boudin C, Deloron P, (2000) Cytoadherence of Plasmodium falciparum-infected erythrocytes in the human placenta. Parasite Immunol 22: 191-199.
12. Beeson JG, Duffy PE, (2005) The immunology and pathogenesis of malaria during pregnancy. Curr Top Microbiol Immunol 297: 187-227.
13. Rowe JA, Moulds JM, Newbold CI, Miller LH, (1997) P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388: 292-295.
14. Smith JD, Craig AG, Kriek N, Hudson-Taylor D, Kyes S, et al. (2000) Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria. Proc Natl Acad Sci U S A 97: 1766-1771.
15. Buffet PA, Gamain B, Scheidig C, Baruch D, Smith JD, et al. (1999) Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. Proc Natl Acad Sci U S A 96: 12743-12748.
16. Reeder JC, Cowman AF, Davern KM, Beeson JG, Thompson JK, et al. (1999) The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1. Proc Natl Acad Sci U S A 96: 5198-5202.
17. Chen Q, Heddini A, Barragan A, Fernandez V, Pearce SF, et al. (2000) The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J Exp Med 192: 1-10.
18. Degen R, Weiss N, Beck HP, (2000) Plasmodium falciparum: cloned and expressed CIDR domains of PfEMP1 bind to chondroitin sulfate A. Exp Parasitol 95: 113-121.
19. Klein MM, Gittis AG, Su H, Makobongo MO, Moore JM, et al. (2008) The cysteine-rich interdomain region from the highly variable plasmodium falciparum erythrocyte membrane protein-1 exhibits a conserved structure. PLoS Pathog 4: e1000147.
20. Mo M, Lee HC, Kotaka M, Niang M, Gao X, et al. (2008) The C-terminal segment of the cysteine-rich interdomain of Plasmodium falciparum erythrocyte membrane protein 1 determines CD36 binding and elicits antibodies that inhibit adhesion of parasite-infected erythrocytes. Infect Immun 76: 1837-1847.
21. Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K, (1989) Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 341: 57-59.
22. Barnwell JW, Asch AS, Nachman RL, Yamaya M, Aikawa M, et al. (1989) A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest 84: 765-772.
23. Ockenhouse CF, Magowan C, Chulay JD, (1989) Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro. J Clin Invest 84: 468-475.
24. Ho M, Schollaardt T, Niu X, Looareesuwan S, Patel KD, et al. (1998) Characterization of Plasmodium falciparum-infected erythrocyte and P-selectin interaction under flow conditions. Blood 91: 4803-4809.
25. Heddini A, Pettersson F, Kai O, Shafi J, Obiero J, et al. (2001) Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect Immun 69: 5849-5856.
26. Staalsoe T, Megnekou R, Fievét N, Ricke CH, Zornig HD, et al. (2001) Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J Infect Dis 184: 618-626.
27. Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, et al. (2004) Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 363: 283-289.
28. Feng G, Aitken E, Yosaatmadja F, Kalilani L, Meshnick SR, et al. (2009) Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. J Infect Dis 200: 299-306.
29. Dahlbäck M, Rask TS, Andersen PH, Nielsen MA, Ndam NT, et al. (2006) Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration. PLoS Pathog 2: e124.
30. van de Stolpe A, van der Saag PT, (1996) Intercellular adhesion molecule-1. J Mol Med 74: 13-33.
31. Fernandez-Reyes D, Craig AG, Kyes SA, Peshu N, Snow RW, et al. (1997) A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 6: 1357-1360.
32. Kun JF, Klabunde J, Lell B, Luckner D, Alpers M, et al. (1999) Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambaréné, Gabon. Am J Trop Med Hyg 61: 776-779.
33. Bellamy R, Kwiatkowski D, Hill AV, (1998) Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans R Soc Trop Med Hyg 92: 312-316.
34. Adams S, Turner GD, Nash GB, Micklem K, Newbold CI, et al. (2000) Differential binding of clonal variants of Plasmodium falciparum to allelic forms of intracellular adhesion molecule 1 determined by flow adhesion assay. Infect Immun 68: 264-269.
35. Craig A, Fernandez-Reyes D, Mesri M, McDowall A, Altieri DC, et al. (2000) A functional analysis of a natural variant of intercellular adhesion molecule-1 (ICAM-1Kilifi). Hum Mol Genet 9: 525-530.
36. Gray C, McCormick C, Turner G, Craig A, (2003) ICAM-1 can play a major role in mediating P. falciparum adhesion to endothelium under flow. Mol Biochem Parasitol 128: 187-193.
37. Gray C, Craig A, (2002) Fibrinogen binding to intercellular adhesion molecule 1: implications for Plasmodium falciparum adhesion. Infect Immun 70: 3962-3964.
38. McGilvray ID, Serghides L, Kapus A, Rotstein OD, Kain KC, (2000) Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood 96: 3231-3240.
39. Febbraio M, Hajjar DP, Silverstein RL, (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108: 785-791.
40. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, et al. (1992) Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 80: 1105-1115.
41. Rogerson SJ, Tembenu R, Dobaño C, Plitt S, Taylor TE, et al. (1999) Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria. Am J Trop Med Hyg 61: 467-472.
42. Chilongola J, Balthazary S, Mpina M, Mhando M, Mbugi E, (2009) CD36 deficiency protects against malarial anaemia in children by reducing Plasmodium falciparum-infected red blood cell adherence to vascular endothelium. Trop Med Int Health 14: 810-816.
43. Beeson JG, Rogerson SJ, Cooke BM, Reeder JC, Chai W, et al. (2000) Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria. Nat Med 6: 86-90.
44. Cooke BM, Berendt AR, Craig AG, MacGregor J, Newbold CI, et al. (1994) Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for ICAM-1, CD36 and thrombospondin. Br J Haematol 87: 162-170.
45. Chakravorty SJ, Craig A, (2005) The role of ICAM-1 in Plasmodium falciparum cytoadherence. Eur J Cell Biol 84: 15-27.
46. Aitman TJ, Cooper LD, Norsworthy PJ, Wahid FN, Gray JK, et al. (2000) Malaria susceptibility and CD36 mutation. Nature 405: 1015-1016.
47. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, et al. (2002) Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359: 1311-1312.
48. Jenkins NE, Mwangi TW, Kortok M, Marsh K, Craig AG, et al. (2005) A polymorphism of intercellular adhesion molecule-1 is associated with a reduced incidence of nonmalarial febrile illness in Kenyan children. Clin Infect Dis 41: 1817-1819.
49. Pain A, Urban BC, Kai O, Casals-Pascual C, Shafi J, et al. (2001) A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 357: 1502-1503.
50. Roberts DJ, Williams TN, (2003) Haemoglobinopathies and resistance to malaria. Redox Rep 8: 304-310.
51. Cholera R, Brittain NJ, Gillrie MR, Lopera-Mesa TM, Diakité SAS, et al. (2008) Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci U S A 105: 991-996.
52. Fairhurst RM, Baruch DI, Brittain NJ, Ostera GR, Wallach JS, et al. (2005) Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria. Nature 435: 1117-1121.
53. Bull PC, Lowe BS, Kortok M, Marsh K, (1999) Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. Infect Immun 67: 733-739.
54. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A, (1989) Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 71: 441-459.
55. Severe falciparum malaria (2000) World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94 (Suppl 1): S1-90.
56. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, et al. (1995) Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404.
57. Marsh K, Snow RW, (1997) Host-parasite interaction and morbidity in malaria endemic areas. Philos Trans R Soc Lond, B, Biol Sci 352: 1385-1394.
58. Bull PC, Kortok M, Kai O, Ndungu F, Ross A, et al. (2000) Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age. J Infect Dis 182: 252-259.
59. Roberts DJ, Craig AG, Berendt AR, Pinches R, Nash G, et al. (1992) Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357: 689-692.
60. Ockenhouse CF, Betageri R, Springer TA, Staunton DE, (1992) Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus. Cell 68: 63-69.
61. Trager W, Jensen JB, (1976) Human malaria parasites in continuous culture. Science 193: 673-675.
62. Tse MT, Chakrabarti K, Gray C, Chitnis CE, Craig A, (2004) Divergent binding sites on intercellular adhesion molecule-1 (ICAM-1) for variant Plasmodium falciparum isolates. Mol Microbiol 51: 1039-1049.
63. Chong SS, Boehm CD, Higgs DR, Cutting GR, (2000) Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 95: 360-362.
64. Waterfall CM, Cobb BD, (2001) Single tube genotyping of sickle cell anaemia using PCR-based SNP analysis. Nucleic Acids Res 29: E119.
65. Liljander A, Wiklund L, Falk N, Kweku M, Mårtensson A, et al. (2009) Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2). Malar J 8: 78.
66. Reeder JC, Rogerson SJ, al-Yaman F, Anders RF, Coppel RL, et al. (1994) Diversity of agglutinating phenotype, cytoadherence, and rosette-forming characteristics of Plasmodium falciparum isolates from Papua New Guinean children. Am J Trop Med Hyg 51: 45-55.
67. Blomqvist K, Normark J, Nilsson D, Ribacke U, Orikiriza J, et al. (2010) var gene transcription dynamics in Plasmodium falciparum patient isolates. Mol Biochem Parasitol 170: 74-83.
68. Chaiyaroj SC, Coppel RL, Novakovic S, Brown GV, (1994) Multiple ligands for cytoadherence can be present simultaneously on the surface of Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci U S A 91: 10805-10808.
69. Cojean S, Jafari-Guemouri S, Le Bras J, Durand R, (2008) Cytoadherence characteristics to endothelial receptors ICAM-1 and CD36 of Plasmodium falciparum populations from severe and uncomplicated malaria cases. Parasite 15: 163-169.
70. Marsh K, Marsh VM, Brown J, Whittle HC, Greenwood BM, (1988) Plasmodium falciparum: the behavior of clinical isolates in an in vitro model of infected red blood cell sequestration. Exp Parasitol 65: 202-208.
71. Kyriacou HM, Stone GN, Challis RJ, Raza A, Lyke KE, et al. (2006) Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Mol Biochem Parasitol 150: 211-218.
72. Ho M, Singh B, Looareesuwan S, Davis TM, Bunnag D, et al. (1991) Clinical correlates of in vitro Plasmodium falciparum cytoadherence. Infect Immun 59: 873-878.
73. Meerman L, Ord R, Bousema JT, van Niekerk M, Osman E, et al. (2005) Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. J Infect Dis 192: 1651-1657.
74. Akech SO, Hassall O, Pamba A, Idro R, Williams TN, et al. (2008) Survival and haematological recovery of children with severe malaria transfused in accordance to WHO guidelines in Kilifi, Kenya. Malar J 7: 256.
75. Serghides L, Kain KC, (2001) Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. J Immunol 166: 6742-6748.
76. Smith TG, Serghides L, Patel SN, Febbraio M, Silverstein RL, et al. (2003) CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum. Infect Immun 71: 393-400.
77. Urban BC, Ferguson DJ, Pain A, Willcox N, Plebanski M, et al. (1999) Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400: 73-77.
78. Elliott SR, Spurck TP, Dodin JM, Maier AG, Voss TS, et al. (2007) Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1. Infect Immun 75: 3621-3632.
79. Calis JCJ, Phiri KS, Faragher EB, Brabin BJ, Bates I, et al. (2008) Severe anemia in Malawian children. N Engl J Med 358: 888-899.
80. Pradhan P, (2009) Malarial anaemia and nitric oxide induced megaloblastic anaemia: a review on the causes of malarial anaemia. J Vector Borne Dis 46: 100-108.
81. Snow RW, Omumbo JA, Lowe B, Molyneux CS, Obiero JO, et al. (1997) Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349: 1650-1654.
82. Marsh K, Snow RW, (1999) Malaria transmission and morbidity. Parassitologia 41: 241-246.
83. O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, et al. (2008) Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 372: 1555-1562.
84. Veenemans J, Andang'o PEA, Mbugi EV, Kraaijenhagen RJ, Mwaniki DL, et al. (2008) Alpha+-thalassemia protects against anemia associated with asymptomatic malaria: evidence from community-based surveys in Tanzania and Kenya. J Infect Dis 198: 401-408.
85. Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA, (2000) Red cell surface changes and erythrophagocytosis in children with severe plasmodium falciparum anemia. Blood 95: 1481-1486.
86. Montgomery J, Mphande FA, Berriman M, Pain A, Rogerson SJ, et al. (2007) Differential var gene expression in the organs of patients dying of falciparum malaria. Mol Microbiol 65: 959-967.
87. Kolatkar PR, Bella J, Olson NH, Bator CM, Baker TS, et al. (1999) Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. EMBO J 18: 6249-6259.
88. Xiao C, Tuthill TJ, Bator Kelly CM, Challinor LJ, Chipman PR, et al. (2004) Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule. J Virol 78: 10034-10044.
89. McCormick CJ, Craig A, Roberts D, Newbold CI, Berendt AR, (1997) Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells. J Clin Invest 100: 2521-2529.
90. Färnert A, Williams TN, Mwangi TW, Ehlin A, Fegan G, et al. (2009) Transmission-dependent tolerance to multiclonal Plasmodium falciparum infection. J Infect Dis 200: 1166-1175.
91. Färnert A, Rooth I, Svensson, Snounou G, Björkman A, (1999) Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. J Infect Dis 179: 989-995.
92. al-Yaman F, Genton B, Taraika J, Anders R, Alpers MP, (1997) Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status. Parasite Immunol 19: 207-214.
93. Engelbrecht F, Felger I, Genton B, Alpers M, Beck HP, (1995) Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes. Exp arasitol 81: 90-96.
94. Touré FS, Ouwe-Missi-Oukem-Boyer O, Mezui-Me-Ndong J, Ndong-Atome GR, Bisvigou U, et al. (2007) Cytoadherence and genotype of Plasmodium falciparum strains from symptomatic children in Franceville, southeastern Gabon. Clin Med Res 5: 106-113.
95. Biswas AK, Hafiz A, Banerjee B, Kim KS, Datta K, et al. (2007) Plasmodium falciparum uses gC1qR/HABP1/p32 as a receptor to bind to vascular endothelium and for platelet-mediated clumping. PLoS Pathog 3: 1271-1280.